Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Tris acetate | 100g Pack Size. Group: Buffers. Formula: NH2C(CH2OH)3 · CH3COOH. CAS No. 6850-28-8. Prepack ID 14463162-100g. Molecular Weight 181.19. See USA prepack pricing. |  |
| Tris Acetate | Tris acetate is used for the production of TAE buffer for molecular biology applications. Group: Biochemicals. Alternative Names: Tris (hydroxymethyl) aminomethane acetate; 2-Amino-2-(hydroxymethyl)-1,3-propanediol acetate; Tromethamine acetate; TRIS acetate salt. Grades: Molecular Biology Grade. CAS No. 6850-28-8. Pack Sizes: 100g, 500g, 1Kg. Molecular Formula: C4H11NO3 C2H4O2, Molecular Weight: 181.19. US Biological Life Sciences. |  Worldwide |
| (1R)-1,5-Anhydro-1-C-1H-indol-2-yl-2,3,4-tris-O-(phenylmethyl)-D-Mannitol 6-Acetate | (1R)-1,5-Anhydro-1-C-1H-indol-2-yl-2,3,4-tris-O-(phenylmethyl)-D-Mannitol 6-Acetate is an intermediate in the synthesis of 2-(α-D-Mannopyranosyl)-L-tryptophan (M166450), a tryptophan glycoconjugate being tested as a diagnostic tool for the accurate measure of renal function. Group: Biochemicals. Grades: Highly Purified. CAS No. 358620-68-5. Pack Sizes: 1mg, 5mg. Molecular Formula: C37H37NO6. US Biological Life Sciences. | Worldwide |
| (1R)-1,5-Anhydro-1-C-1H-indol-2-yl-2,3,4-tris-O-(phenylmethyl)-D-Mannitol 6-Acetate-d4 | (1R)-1,5-Anhydro-1-C-1H-indol-2-yl-2,3,4-tris-O-(phenylmethyl)-D-Mannitol 6-Acetate-d4 is an isotope labelled intermediate in the synthesis of 2-(α-D-Mannopyranosyl)-L-tryptophan (M166450), a tryptophan glycoconjugate being tested as a diagnostic tool for the accurate measure of renal function. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 5mg. Molecular Formula: C37H33D4NO6. US Biological Life Sciences. | Worldwide |
| [1S-(1α, 4α, 5β, 6α)]-4, 6-Dideoxy-4-[[4, 5, 6-tris(acetyloxy)-3-[(acetyloxy)methyl]-2-cyclohexen-1-yl]amino]-α-D-glucopyranoside 2,3-Diacetate Methyl Ester | [1S-(1α, 4α, 5β, 6α)]-4, 6-Dideoxy-4-[[4, 5, 6-tris(acetyloxy)-3-[(acetyloxy)methyl]-2-cyclohexen-1-yl]amino]-α-D-glucopyranoside 2,3-Diacetate Methyl Ester is an intermediate in the synthesis of Pseudo Acarbose, an homolog of Acarbose, used in the treatment of diabetes. Synonyms: DTXSID601100354; 80943-42-6; alpha-D-Glucopyranoside, methyl 4,6-dideoxy-4-[[4,5,6-tris(acetyloxy)-3-[(acetyloxy)methyl]-2-cyclohexen-1-yl]amino]-, 2,3-diacetate, [1S-(1alpha,4alpha,5beta,6alpha)]-. CAS No. 80943-42-6. Molecular formula: C26H37NO14. Mole weight: 587.57. |  |
| [1S-(1α,4α,5 β,6α)]-4,6-Dideoxy-4-[[4,5,6-tris(acetyloxy)-3-[(acetyloxy)methyl]-2-cyclohexen-1-yl]amino]-α-D-glucopyranoside 2,3-Diacetate Methyl Ester | [1S-(1α,4α,5 β,6α)]-4,6-Dideoxy-4-[[4,5,6-tris(acetyloxy)-3-[(acetyloxy)methyl]-2-cyclohexen-1-yl]amino]-α-D-glucopyranoside 2,3-Diacetate Methyl Ester is an intermediate in the synthesis of Pseudo Acarbose, an homolog of Acarbose (A123500), used in the treatment of diabetes (1). Group: Biochemicals. Grades: Highly Purified. CAS No. 80943-42-6. Pack Sizes: 100mg, 1g. Molecular Formula: C26H37NO14. US Biological Life Sciences. | Worldwide |
| 2,3,4-Tris-O-(phenylmethyl)-α-D-mannopyranose 6-Acetate 1-(2,2,2-Trichloroethanimidate | 2,3,4-Tris-O-(phenylmethyl)-α-D-mannopyranose 6-Acetate 1-(2,2,2-Trichloroethanimidate is an intermediate used in the stereocontrolled syntheses of α-C-mannosyltryptophan and its analogues. Group: Biochemicals. Grades: Highly Purified. CAS No. 208712-66-7. Pack Sizes: 250mg, 500mg. Molecular Formula: C31H32Cl3NO7. US Biological Life Sciences. | Worldwide |
| 2-(4-Nitrophenyl)sulfanylacetate; tris(2-hydroxyethyl)azanium | Heterocyclic Organic Compound. Alternative Names: ((4-Nitrophenyl)thio)acetic acid 2,2,2-nitrilotris(ethanol) (1:1); 2-(4-nitrophenyl)sulfanylacetate; tris(2-hydroxyethyl)azanium; 2-hydroxy-N,N-bis(2-hydroxyethyl)ethanaminium [(4-nitrophenyl)sulfanyl]acetate; Acetic acid,((4-nitrophenyl)thio)-,compd. wit. CAS No. 102582-90-1. Molecular formula: C14H22N2O7S. Mole weight: 362.399 g/mol. Purity: 0.96. IUPACName: 2-(4-nitrophenyl)sulfanylacetate;tris(2-hydroxyethyl)azanium. Canonical SMILES: C1=CC (=CC=C1[N+] (=O)[O-])SCC (=O)[O-]. C (CO)[NH+] (CCO)CCO. Catalog: ACM102582901. |  |
| 2,6-Anhydro-7,8-dideoxy-3,4,5-tris-O-(phenylmethyl)-D-glycero-D-manno-Oct-7-ynitol Acetate | 2,6-Anhydro-7,8-dideoxy-3,4,5-tris-O-(phenylmethyl)-D-glycero-D-manno-Oct-7-ynitol Acetate is an intermediate used in the stereocontrolled syntheses of α-C-mannosyltryptophan and its analogues. Group: Biochemicals. Grades: Highly Purified. CAS No. 220339-86-6. Pack Sizes: 10mg, 25mg. Molecular Formula: C31H32O6. US Biological Life Sciences. | Worldwide |
| (2R, 3R, 4S)-2-[3, 4-Bis (phenylmethoxy)phenyl]-3, 4-dihydro-3, 5, 7-tris (phenylmethoxy)-2H-1-benzopyran-4-ol 4-Acetate | (2R, 3R, 4S)-2-[3, 4-Bis (phenylmethoxy)phenyl]-3, 4-dihydro-3, 5, 7-tris (phenylmethoxy)-2H-1-benzopyran-4-ol 4-Acetate is an intermediate in the synthesis of (+)-trans Taxifolin (T010005), an antioxidant flavenoid. Group: Biochemicals. Grades: Highly Purified. CAS No. 478241-14-4. Pack Sizes: 10mg, 25mg. Molecular Formula: C52H46O8. US Biological Life Sciences. | Worldwide |
| 1-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)imidazole | 1-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)imidazole, a highly efficient glycosylation reagent, has shown remarkable utility in the synthesis of glycans and glycoconjugates. Its applications have expanded to the development of glycoside hydrolase inhibitors as well as in the preparation of oligosaccharides. The versatility and efficacy of this chemical compound make it a valuable tool in glycosylation research. Synonyms: 1-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)imidazole; 38953-70-7; [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-imidazol-1-yloxan-2-yl]methyl acetate; DTXSID60855871; 1-(2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranosyl)-1H-imidazole; [(2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-(1H-imidazol-1-yl)oxan-2-yl]methyl acetate; (2R,3R,4S,5R,6R)-2-(acetoxymethyl)-6-(1H-imidazol-1-yl)tetrahydro-2H-pyran-3,4,5-triyl triacetate. CAS No. 38953-70-7. Molecular formula: C17H22N2O9. Mole weight: 398.4. | |
| 1,2,3,4-Tetra-O-acetyl-a-L-fucopyranose | 1,2,3,4-Tetra-O-acetyl-a-L-fucopyranose, a paramount compound in the biomedical field, finds extensive utility in the synthesis of pharmaceutical agents that combat diverse maladies such as cancer, inflammation, and infectious diseases. Remarkably crucial in the realm of drug discovery and development, this product assumes a paramount position by selectively engaging disease mechanisms, thereby facilitating the efficacious treatment across a multitude of conditions. Synonyms: 1,2,3,4-Tetra-O-acetyl-a-L-fucopyranose; 1,2,3,4-tetra-O-acetyl-alpha-L-fucopyranose; (2S,3S,4R,5R,6S)-6-Methyltetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate; [(2S,3R,4R,5S,6S)-4,5,6-triacetyloxy-2-methyloxan-3-yl] acetate; (2S,3R,4R,5S,6S)-4,5,6-TRIS(ACETYLOXY)-2-METHYLOXAN-3-YL ACETATE; Discontinued. See T279255; SCHEMBL7153152; QZQMGQQOGJIDKJ-CSHNMWLISA-N; AKOS027327484; AS-73051; 1,2,3,4-Tetra-O-acetyl-?-L-fucopyranose; CS-0187881; 1,2,3,4-Tetra-O-acetyl-alpha-L(-)-fucose; T72773; A923735; 1,2,3,4-Tetra-O-acetyl-alpha-L-fucopyranose, 95%; 1,2,3,4-tetra-O-acetyl-6-deoxy-alpha-L-galactopyranose; (2S,3S,4R,5R,6S)-6-Methyltetrahydro-2H-pyran-2,3,4,5-tetrayltetraacetate; 1,2,3,4-Tetra-O-acetyl-alpha-L(-)-fucose, Tetra-O-acetyl-alpha-L(-)fucopyranose. CAS No. 64913-16-2. Molecular formula: C14H20O9. Mole weight: 332.3. | |
| 1,2,3,4-Tetra-O-acetyl-b-D-arabinopyranose | 1,2,3,4-Tetra-O-acetyl-b-D-arabinopyranose, a compound of immense significance in the biomedical sector, is characterized by its fundamental role in the domain of pharmaceutical research and development. Derived from arabinose, this invaluable product serves as a pivotal precursor for the synthesis of diverse drugs and therapies employed in combating infectious diseases, namely HIV/AIDS. Synonyms: [(3R,4R,5S,6R)-4,5,6-triacetyloxyoxan-3-yl] acetate; 1,2,3,4-tetra-o-acetyl-alpha-d-arabinopyranose; (2R,3S,4R,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate; Acetyl 2-O,3-O,4-O-triacetyl-alpha-D-arabinopyranoside; 1,2,3,4-Tetra-O-acetyl-a-D-arabinopyranose; SCHEMBL5344597; DTXSID701269511; alpha-D-Arabinopyranose, 1,2,3,4-tetraacetate; (2R,3S,4R,5R)-3,4,5-TRIS(ACETYLOXY)OXAN-2-YL ACETATE. CAS No. 108646-05-5. Molecular formula: C13H18O9. Mole weight: 318.28. | |
| 1,2,3,4-Tetra-O-acetyl-D-mannopyranose | 1,2,3,4-Tetra-O-acetyl-D-mannopyranose, a versatile chemical compound that finds extensive applications within the biopharmaceutical domain. Its primary function as a key starting material in the synthesis of pharmacologically active carbohydrate-based drugs has garnered much attention in scientific circles. Furthermore, this compound also serves as a vital substrate for the identification and characterization of diverse enzymatic processes involved in carbohydrate metabolism, thus offering researchers invaluable insights into complex biological mechanisms. Synonyms: 1,2,3,4-Tetra-O-acetyl-D-mannopyranose; 51008-88-9; [(2R,3R,4S,5R,6S)-4,5,6-triacetyloxy-2-(hydroxymethyl)oxan-3-yl] acetate; [4,5,6-triacetyloxy-2-(hydroxymethyl)oxan-3-yl] acetate; D-Glucopyranose, 1,2,3,4-tetraacetate; beta-D-Mannopyranose 1,2,3,4-tetraacetate; 1,2,3,4-Tetra-O-acetyl-D-galactopyranose; 28154-37-2; 65620-65-7; 78148-86-4; SCHEMBL9616862; DTXSID10927032; NSC409250; 1,2,3,4-Tetra-O-acetylhexopyranose; NSC-409250; A888631; 4,5,6-TRIS(ACETYLOXY)-2-(HYDROXYMETHYL)OXAN-3-YL ACETATE. CAS No. 51008-88-9. Molecular formula: C14H20O10. Mole weight: 348.30. | |
| 1,2,3,5,6-Penta-O-acetyl-D-galactofuranose | 1,2,3,5,6-Penta-O-acetyl-D-galactofuranose: An intriguing compound obtained from D-galactose, exhibiting immense potential in the field of biomedical research. Renowned for its acetylated variant, it serves as a fundamental building block in the synthesis of diverse carbohydrate derivatives, holding immense promise for therapeutic interventions. Elucidating its distinctive structural attributes, this compound emerges as a compelling candidate for drug development, specifically targeting afflictions including cancer, bacterial infections, and inflammatory disorders. Synonyms: D-Galactofuranose Pentaacetate; 1,2,3,5,6-PENTA-O-ACETYL-D-GALACTOFURANOSE; [(2R)-2-acetyloxy-2-[(2S,3S,4R)-3,4,5-triacetyloxyoxolan-2-yl]ethyl] acetate; SCHEMBL5696788; (1R)-2-(ACETYLOXY)-1-[(2S,3S,4R)-3,4,5-TRIS(ACETYLOXY)OXOLAN-2-YL]ETHYL ACETATE. CAS No. 62181-82-2. Molecular formula: C16H22O11. Mole weight: 390.4. | |
| 1,3,4,6-Tetra-O-acetyl-a-D-glucopyranose | 1,3,4,6-Tetra-O-acetyl-a-D-glucopyranose, an indispensable molecule in the biomedical industry, is extensively employed for synthesizing diverse pharmaceutical drugs. Its primary function lies in its application as a safeguarding agent during glycosidic bond formation. Synonyms: 1,3,4,6-Tetra-O-acetyl-alpha-D-glucopyranose; 4692-12-0; 4292-12-0; [(2R,3R,4R,5R,6R)-3,4,6-triacetyloxy-5-hydroxyoxan-2-yl]methyl acetate; (2R,3R,4R,5R,6R)-6-(acetoxymethyl)-3-hydroxytetrahydro-2H-pyran-2,4,5-triyl triacetate; [(2R,3R,4R,5R,6R)-3,4,6-TRIS(ACETYLOXY)-5-HYDROXYOXAN-2-YL]METHYL ACETATE.alpha.-D-Glucopyranose,1,3,4,6-tetraacetate; SCHEMBL1337942; DTXSID401281122; BS-28046; 1,3,4,6-Tetra-O-acetylalpha-D-glucopyranose; alpha-D-Glucopyranose, 1,3,4,6-tetraacetate. CAS No. 4292-12-0. Molecular formula: C14H20O10. Mole weight: 348.3. | |
| 1,4,7-Tris(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane | Heterocyclic Organic Compound. Alternative Names: 1,4,7-Tris(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane;1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-ethyl acetate)DO3A-t-Ethyl ester;Triethyl 2,2,2-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate. CAS No. 114873-52-8. Molecular formula: C20H38N4O6. Purity: 0.96. IUPACName: ethyl 2-[4,7-bis(2-ethoxy-2-oxoethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate. Canonical SMILES: CCOC (=O)CN1CCNCCN (CCN (CC1)CC (=O)OCC)CC (=O)OCC. Density: 1.064. Catalog: ACM114873528. | |
| 1,4,8,11-Tetrakis(ethoxycarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane | Heterocyclic Organic Compound. Alternative Names: 126320-57-8, 1,4,8,11-TETRAKIS(ETHOXYCARBONYLMETHYL)-1,4,8,11-TETRAAZACYCLOTETRADECANE, Tetraethyl 1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetate, SureCN689078, AGN-PC-001EVP, ACMC-1C3A0, CTK8A9920, ANW-18923, AKOS015854209, T2540, 1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetic Acid Tetraethyl Ester, ethyl 2-[4,8,11-tris(2-ethoxy-2-oxoethyl)-1,4,8,11-tetrazacyclotetradec-1-yl]acetate. CAS No. 126320-57-8. Molecular formula: C26H48N4O8. Mole weight: 544.681320 [g/mol]. Purity: >97.0%(GC). IUPACName: ethyl 2-[4,8,11-tris(2-ethoxy-2-oxoethyl)-1,4,8,11-tetrazacyclotetradec-1-yl]acetate. Density: 1.07g/cm³. Catalog: ACM126320578. | |
| 1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-a-D-mannopyranose | 1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-α-D-mannopyranose, a multifaceted molecule employed in biomedicine, exhibits immense potential. This compound, renowned for its distinctive configuration, has garnered considerable attention in the fight against cancer, viral infections, and inflammatory ailments. Its role as a precursor in the synthesis of various pharmaceuticals used to combat diverse diseases has prompted extensive scientific exploration. Synonyms: ((2R,3R,4S,5S,6R)-6-Acetoxy-3,4,5-tris(benzyloxy)tetrahydro-2H-pyran-2-yl)methyl acetate; 1,6-DI-O-ACETYL-2,3,4-TRI-O-BENZYL-ALPHA-D-MANNOPYRANOSE; 1,6-Di-o-acetyl-2,3,4-tri-o-benzyl-a-D-mannopyranose; ((2R,3R,4S,5S,6R)-6-Acetoxy-3,4,5-tris(benzyloxy)-tetrahydro-2H-pyran-2-yl)methyl acetate; [(2R,3R,4S,5S,6R)-6-acetyloxy-3,4,5-tris(phenylmethoxy)oxan-2-yl]methyl acetate; 1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-|A-D-mannopyranose;1,5-Di-O-acetyl-2,3,4-tri-O-benzyl-alpha-D-mannopyranoside; 1,6-Di-O-acetyl-2,3,4-tri-O-benzyl- alpha -D-mannopyranose; 2,3,4-Tris-O-(phenylmethyl)-alpha-D-mannopyranose 1,6-Diacetate; ((2R,3R,4S,5S,6R)-6-Acetoxy-3,4,5-tris(benzyloxy)tetrahydro-2H-pyran-2-yl)methylacetate; [(2R,3R,4S,5S,6R)-6-(ACETYLOXY)-3,4,5-TRIS(BENZYLOXY)OXAN-2-YL]METHYL ACETATE. CAS No. 65556-30-1. Molecular formula: C31H34O8. Mole weight: 534.6. | |
| 1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-D-glucopyranose | 1,6-Di-O-acetyl-2,3,4-tri-O-benzyl-D-glucopyranose, renowned for its indispensable contribution in the advancement and synthesis of diverse pharmacological substances, embodies a paramount interim compound. Its unparalleled molecular configuration propels medicinal chemistry exploration, fostering the emergence of potential remedies against malignant neoplasms, diabetes mellitus, and viral affections. Synonyms: 1,6-DI-O-ACETYL-2,3,4-TRI-O-BENZYL-D-GLUCOPYRANOSE; 59433-13-5; [(2R,3R,4S,5R)-6-acetyloxy-3,4,5-tris(phenylmethoxy)oxan-2-yl]methyl acetate; 1,6-DI-O-ACETYL-2,3,4-TRI-O-BENZYL-ALPHA,BETA-D-GLUCOPYRANOSE; SCHEMBL1315625; DTXSID90447061; AKOS030242515; 1,6-Di-O-acetyl- 2,3,4-tri-O-benzyl-D-glucopyranose; 1,6-Di-O-acetyl-2,3,4-tri-O-benzyl- alpha , beta -D-glucopyranose. CAS No. 59433-13-5. Molecular formula: C31H34O8. Mole weight: 534.6. | |
| 1-O-Acetyl-2,3,5-tri-O-benzyl-b-D-ribofuranose | 1-O-Acetyl-2,3,5-tri-O-benzyl-b-D-ribofuranose is a crucial compound in drug synthesis within the biomedical industry. It is commonly used as a precursor or reagent in the manufacturing of antiviral drugs, such as nucleoside analogues. Synonyms: 1-O-Acetyl-2,3,5-tri-O-benzyl-b-D-ribofuranose; 2,3,5-Tris-O-benzyl-beta-D-ribofuranose acetate; SCHEMBL11255942; W-204048; (2S,3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-yl acetate; [(2S,3R,4R,5R)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-yl] acetate. CAS No. 91110-24-6. Molecular formula: C28H30O6. Mole weight: 462.53. | |
| 1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose | 1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose is a pharmaceutical intermediate used in the synthesis of nucleosides. It's specifically utilized within the research and development of treatments for viral diseases like Hepatitis and HIV. Synonyms: 1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose; 58381-23-0; [(3R,4R,5R)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-yl] acetate; (3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-yl acetate; D-Ribofuranose, 2,3,5-tris-O-(phenylmethyl)-, acetate; DTXSID90556349; AKOS016010561; BS-28920; D87696; W-203188; (3R,4R,5R)-3,4-bis(benzyloxy)-5-(benzyloxymethyl)tetrahydrofuran-2-yl acetate; (3R,4R,5R)-3,4-BIS(BENZYLOXY)-5-[(BENZYLOXY)METHYL]OXOLAN-2-YL ACETATE. CAS No. 58381-23-0. Molecular formula: C28H30O6. Mole weight: 462.53. | |
| 1-O-Acetyl-2,3,5-tri-O-p-chlorobenzoyl-b-D-ribofuranose | 1-O-Acetyl-2,3,5-tri-O-p-chlorobenzoyl-b-D-ribofuranose is a crucial compound employed in the biomedical industry. It acts as a precursor for the synthesis of chemotherapeutic drugs used in the treatment of various diseases. Its unique structure allows for targeted drug delivery. Synonyms: 1-O-Acetyl-2,3,5-tri-O-(4-chlorobenzoyl)-beta-D-ribofuranose; [(2R,3R,4R,5S)-5-acetyloxy-3,4-bis[(4-chlorobenzoyl)oxy]oxolan-2-yl]methyl 4-chlorobenzoate; beta-D-Ribofuranose, 1-acetate 2,3,5-tris(4-chlorobenzoate); 1-O-Acetyl 2,3,5-Tri-O-p-chlorobenzoyl-beta-D-ribofuranoside; DiBoc-iodo-L-tyrosine; 1-O-Acetyl-2,3,5-tri-O-p-chlorobenzoyl-b-D-ribofuranose; 1-O-Acetyl 2,3,5-Tri-O-p-chlorobenzoyl-|A-D-ribofuranoside; BenzylN,N-dimethyldithiocarbamate; DTXSID40439491; AKOS016010523; A901117; W-201255; 1-O-Acetyl 2,3,5-Tri-O-p-chlorobenzoyl-?-D-ribofuranoside; 1-O-Acetyl 2,3,5-Tri-O-p-chlorobenzoyl-b-D-ribofuranoside; 1-O-Acetyl 2,3,5-Tri-O-p-chlorobenzoyl- beta -D-ribofuranoside; 1-O-Acetyl-2,3,5-tris-O-(4-chlorobenzoyl)-beta-D-ribofuranose; (2R,3R,4R,5S)-5-(ACETYLOXY)-4-(4-CHLOROBENZOYLOXY)-2-[(4-CHLOROBENZOYLOXY)METHYL]OXOLAN-3-YL 4-CHLOROBENZOATE. CAS No. 144084-01-5. Molecular formula: C28H21Cl3O9. Mole weight: 607.82. | |
| 2,3,4,6-Tetra-O-acetyl-a-D-glucopyranosyl chloride | 2,3,4,6-Tetra-O-acetyl-a-D-glucopyranosyl chloride, an indispensable intermediary compound, holds immense significance in the realm of biomedical industry owing to its vast utilization in diverse drug and compound synthesis. With its pivotal role in the creation of antiviral drugs like nucleoside analogs, it emerges as a critical component in combating viral afflictions such as HIV/AIDS and hepatitis. Furthermore, this compound showcases its utility in the realms of carbohydrate chemistry and pharmaceutical research. Synonyms: 2,3,4,6-Tetra-o-acetyl-alpha-D-glucopyranosyl chloride; (2R,3R,4S,5R,6R)-2-(Acetoxymethyl)-6-chlorotetrahydro-2H-pyran-3,4,5-triyl triacetate; [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-chlorooxan-2-yl]methyl acetate; SCHEMBL7150633; AKOS015896854; (2R,3R,4S,5R,6R)-2-(Acetoxymethyl)-6-chlorotetrahydro-2H-pyran-3,4,5-triyltriacetate; I+/--D-Glucopyranosyl chloride, tetraacetate; A826608; [(2R,3R,4S,5R,6R)-3,4,5-TRIS(ACETYLOXY)-6-CHLOROOXAN-2-YL]METHYL ACETATE. CAS No. 4451-35-8. Molecular formula: C14H19ClO9. Mole weight: 366.8. | |
| 2,3,4,6-Tetra-O-acetyl-a-D-mannopyranosyl bromide - stabilised with 2% CaCO3 | 2,3,4,6-Tetra-O-acetyl-a-D-mannopyranosyl bromide - stabilised with 2% CaCO3 is a glycosyl donor used in synthesis of glycosides and oligosaccharides, useful in drug research and development aimed at diabetes, cancer and infectious diseases. Synonyms: 2,3,4,6-tetra-o-acetyl-alpha-d-mannopyranosyl bromide; Bromo 2,3,4,6-Tetra-O-acetyl-alpha-D-mannopyranoside; (2R,3R,4S,5S,6R)-2-(acetoxymethyl)-6-bromotetrahydro-2H-pyran-3,4,5-triyl triacetate; Acetobromomannose; [(2R,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-bromooxan-2-yl]methyl acetate; alpha-D-Mannopyranosyl bromide, 2,3,4,6-tetraacetate; Bromo 2,3,4,6-Tetra-O-acetyl-alpha-D-mannopyranoside(Stabilized with 4per cent CaCO3); Tetra-O-acetyl-alpha-D-mannosyl bromide;Bromo 2,3,4,6-Tetra-O-acetyl-?-D-mannopyranoside; J-006176; 2,3,4,6-Tetra-o-acetyl-alpha-d-mannopyranosylbromide; Bromo 2,3,4,6-Tetra-O-acetyl- alpha -D-mannopyranoside; (2R,3R,4S,5S,6R)-2-(acetoxymethyl)-6-bromotetrahydro-2H-pyran-3,4,5-triyltriacetate; [(2R,3R,4S,5S,6R)-3,4,5-tris(acetyloxy)-6-bromooxan-2-yl]methyl acetate; Bromo 2,3,4,6-Tetra-O-acetyl-a-D-mannopyranoside(Stabilized with 4% CaCO3). CAS No. 13242-53-0. Molecular formula: C14H19BrO9. Mole weight: 411.2. | |
| 2,3,4,6-Tetra-O-acetyl-a-D-mannopyranosyl fluoride | 2,3,4,6-Tetra-O-acetyl-a-D-mannopyranosyl fluoride, a synthetic compound, finds utility in the pharmaceutical sector as a substrate for producing carbohydrate-based therapies. It's feasible as a building block for the treatment of afflictions such as inflammation, viral infections, and cancer. Notably, the compound's bespoke structure endows it with the potential to target specific cell surface receptors with precision, imparting increased value as a tool in drug discovery and development. Synonyms: 2,3,4,6-TETRA-O-ACETYL-ALPHA-D-MANNOPYRANOSYL FLUORIDE; Acetofluoro-alpha-D-mannose; [(2R,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-fluorooxan-2-yl]methyl acetate; MFCD00792706; (2R,3R,4S,5S,6R)-2-(Acetoxymethyl)-6-fluorotetrahydro-2H-pyran-3,4,5-triyl triacetate; tetra-o-acetyl-alpha-d-mannopyranosyl fluoride; Acetofluoro- alpha -D-mannose; SCHEMBL2037245; DTXSID40460700; JJXATNWYELAACC-DGTMBMJNSA-N; 2,3,4,6-TETRA-O-ACETYL-ALPHA-D-MANNOPYRANOSYLFLUORIDE; AC8160; AKOS015912717; BS-28127; Tetra-O-acetyl--D-mannopyranosyl fluoride; (2R,3R,4S,5S,6R)-2-(Acetoxymethyl)-6-fluorotetrahydro-2H-pyran-3,4,5-triyltriacetate; [(2R,3R,4S,5S,6R)-3,4,5-TRIS(ACETYLOXY)-6-FLUOROOXAN-2-YL]METHYL ACETATE. CAS No. 2823-44-1. Molecular formula: C14H19FO9. Mole weight: 350.29. | |
| 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl amine | 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl amine, also known as a highly potent biomedical compound, has been extensively studied for its effectiveness in the treatment of diverse diseases. By functioning as a potential antiviral agent, it has shown remarkable therapeutic capabilities against viral infections. Its mode of action involves the inhibition of viral replication and dissemination, rendering it an encouraging prospect in the battle against viral illnesses. Synonyms: (2R,3R,4S,5R,6R)-2-(acetoxymethyl)-6-aminotetrahydro-2H-pyran-3,4,5-triyl triacetate; 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl amine; 2,3,4,6-tetra-o-acetyl-beta-d-glucopyranosyl amine; 2,3,4,6-TETRA-O-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE; SCHEMBL1682155; [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-aminooxan-2-yl]methyl acetate; CHEMBL3775497; MFCD06657654; AKOS027327931; Tetra-o-acetyl-beta-D-glucopyranosylamine; F13336; A871215; 2,3,4,6-Tetra-O-acetyl-??-D-glucopyranosyl amine; W-202948; 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl_amine; (2R,3R,4S,5R,6R)-2-(acetoxymethyl)-6-aminotetrahydro-2H-pyran-3,4,5-triyltriacetate; [(2R,3R,4S,5R,6R)-3,4,5-TRIS(ACETYLOXY)-6-AMINOOXAN-2-YL]METHYL ACETATE. CAS No. 51642-81-0. Molecular formula: C14H21NO9. Mole weight: 347.32. | |
| 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl trichloroacetimidate | 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl trichloroacetimidate, a highly significant compound extensively employed in the biomedicine sector, serves as a multifaceted reagent within the oligosaccharide synthesis domain. Its primary purpose lies in glycosylating diverse pharmaceuticals and biomolecules. This invaluable product expedites the advancement of pioneering therapeutic interventions, contributing to the precise management of afflictions encompassing cancer, autoimmune disorders, as well as viral infections. Synonyms: 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl trichloroacetimidate; 2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranosyl 2,2,2-Trichloroacetimidate; [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-(2,2,2-trichloroethanimidoyl)oxyoxan-2-yl]methyl acetate; SCHEMBL1726948; DTXSID00452848; AMY41454; AKOS016844828; CS-W006443; AS-72793; A860167; W-204069; 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyltrichloroacetimidate; 2,3,4,6-Tetra-O-acetyl-1-O-(2,2,2-trichloroethanimidoyl)-beta-D-glucopyranose; [(2R,3R,4S,5R,6S)-3,4,5-TRIS(ACETYLOXY)-6-[(2,2,2-TRICHLOROETHANIMIDOYL)OXY]OXAN-2-YL]METHYL ACETATE. CAS No. 92052-29-4. Molecular formula: C16H20Cl3NO10. Mole weight: 492.69. | |
| 2,3,4,6-Tetra-O-acetyl-b-D-mannopyranose | 2,3,4,6-Tetra-O-acetyl-b-D-mannopyranose, a multi-talented intermediary in the construction of intricate carbohydrates and glycoconjugates, is regularly employed in the arena of biomedicine. Its vast potentialities in the exploration of glycosylation and the exploration of carbohydrate-based remedies for diseases including cancer and viral infections cannot be undermined. Synonyms: 2,3,4,6-tetra-O-acetyl-b-D-mannopyranose; 57884-82-9; [(2R,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-hydroxyoxan-2-yl]methyl acetate; [(2R,3R,4S,5S,6R)-3,4,5-TRIS(ACETYLOXY)-6-HYDROXYOXAN-2-YL]METHYL ACETATE; 2,3,4,6-Tetra-O-acetyl-beta-D-mannopyranose; SCHEMBL5179435; DTXSID00481739; (2R,3R,4S,5S,6R)-2-(acetoxymethyl)-6-hydroxytetrahydro-2H-pyran-3,4,5-triyl triacetate. CAS No. 57884-82-9. Molecular formula: C14H20O10. Mole weight: 348.3. | |
| 2,3,4,6-Tetra-O-acetyl-D-mannopyranosyl Fluoride | 2,3,4,6-Tetra-O-acetyl-D-mannopyranosyl Fluoride is a valuable tool in the biomedical industry. This compound serves as a chemical substrate used in enzymatic reactions for the synthesis of pharmaceutical drugs. Specifically, it is utilized in the manufacturing process of antiviral and antitumor compounds, targeting various diseases such as HIV and cancer. Its purity and reliable characteristics make it an essential component in biomedical research and drug development. Synonyms: 2,3,4,6-Tetra-O-acetyl-D-mannopyranosyl Fluoride; (2R,3R,4S,5S)-2-(Acetoxymethyl)-6-fluorotetrahydro-2H-pyran-3,4,5-triyl triacetate; D-Mannopyranosyl fluoride, 2,3,4,6-tetraacetate; [(2R,3R,4S,5S)-3,4,5-TRIS(ACETYLOXY)-6-FLUOROOXAN-2-YL]METHYL ACETATE; SCHEMBL8579675; [(2R,3R,4S,5S)-3,4,5-triacetyloxy-6-fluorooxan-2-yl]methyl acetate; AKOS015896816; HY-W145569; AS-67342; CS-0214559; T71928; (2R,3R,4S,5S)-2-(Acetoxymethyl)-6-fluorotetrahydro-2H-pyran-3,4,5-triyltriacetate. CAS No. 174511-17-2. Molecular formula: C14H19FO9. Mole weight: 350.29. | |
| 2-Chloro-4-nitrophenyl 2,3,4,6-tetra-O-acetyl-a-D-glucopyranoside | 2-Chloro-4-nitrophenyl 2,3,4,6-tetra-O-acetyl-a-D-glucopyranoside is an eminent compound found in the biomedical sector, exhibiting promise as a foundational substrate for synthesizing diverse pharmaceutical compounds. Synonyms: [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(2-chloro-4-nitrophenoxy)oxan-2-yl]methyl acetate; 2-Chloro-4-nitrophenyl-2,3,4,6-tetra-O-acetyl-?-D-glucopyranoside; a-D-Glucopyranoside,2-chloro-4-nitrophenyl,2,3,4,6-tetraacetate; 2-Chloro-4-nitrophenyl-2,3,4,6-tetra-O-acetyl-alpha-D-glucopyranoside; (2R,3R,4S,5R,6R)-2-(Acetoxymethyl)-6-(2-chloro-4-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate; [(2R,3R,4S,5R,6R)-3,4,5-TRIS(ACETYLOXY)-6-(2-CHLORO-4-NITROPHENOXY)OXAN-2-YL]METHYL ACETATE. CAS No. 153823-58-6. Molecular formula: C20H22ClNO12. Mole weight: 503.84. | |
| 4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-a-D-mannopyranoside | 4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside is a bioactive compound utilized in biomedicine for its potential therapeutic properties. This product is extensively investigated for its role in treating various diseases, particularly those involving carbohydrate metabolism and signal transduction pathways. Synonyms: 4-Methoxyphenyl 2,3,4,6-Tetra-O-acetyl-alpha-D-mannopyranoside; (2R,3R,4S,5S,6R)-2-(Acetoxymethyl)-6-(4-methoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate; 4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-a-D-mannopyranoside; [(2R,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-(4-methoxyphenoxy)oxan-2-yl]methyl acetate; [(2R,3R,4S,5S,6R)-3,4,5-TRIS(ACETYLOXY)-6-(4-METHOXYPHENOXY)OXAN-2-YL]METHYL ACETATE; DTXSID30536903; 4-Methoxyphenyl-2,3,4,6-tetra-O-acetyl-b-D-mannopyranoside; AKOS027257508; AS-74654; CS-0214557; M1647; T71910; A882021; 4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-|A-D-mannopyranoside; 4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-alpha-D-mannopyranoside, 97%; (2R,3R,4S,5S,6R)-2-(Acetoxymethyl)-6-(4-methoxyphenoxy)tetrahydro-2H-pyran-3,4,5-triyltriacetate. CAS No. 17042-40-9. Molecular formula: C21H26O11. Mole weight: 454.42. | |
| 4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl-a-D-mannopyranoside | 4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside is a crucial reagent in biomedicine. Used primarily in enzymatic assays, it serves as a substrate for detecting and quantifying enzymes involved in lysosomal storage diseases. This compound enables the identification and analysis of various diseases related to glycosylation and enzyme deficiencies, providing valuable insights into therapeutic interventions and drug development. Synonyms: 4-Methylumbelliferyl 2,3,4,6-Tetra-O-acetyl-alpha-D-mannopyranoside; 4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl-a-D-mannopyranoside; [(2R,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-2-yl]methyl acetate; 2H-1-Benzopyran-2-one, 4-methyl-7-[(2,3,4,6-tetra-O-acetyl-alpha-D-mannopyranosyl)oxy]-; 4-Methylumbelliferyl2,3,4,6-tetra-O-acetyl-a-D-mannopyranoside; AKOS015919227; W-202193; 4-Methylumbelliferyl 2,3,4,6-Tetra-O-acetyl-?-D-mannopyranoside; 4-Methyl-2-oxo-2H-1-benzopyran-7-yl alpha-D-Mannopyranoside Tetraacetate; 4-Methylumbelliferyl 2,3,4,6-tetra-O-acetyl- alpha -D-mannopyranoside; (2R,3R,4S,5S,6R)-2-(Acetoxymethyl)-6-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate; [(2R,3R,4S,5S,6R)-3,4,5-tris(acetyloxy)-6-[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]oxan-2-yl]methyl acetate. CAS No. 28541-71-1. Molecular formula: C24H26O12. Mole weight: 506.46. | |
| 4-Methylumbelliferyl 2-acetamido-3-O-(2,3,4-tri-O-acetyl-a-L-fucopyranosyl)-4-O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-6-O-acetyl-2-deoxy-b-D-glucopyranoside | 4-Methylumbelliferyl 2-acetamido-3-O-(2,3,4-tri-O-acetyl-α-L-fucopyranosyl)-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-6-O-acetyl-2-deoxy-β-D-glucopyranoside is a compound primarily employed as a substrate for enzyme assays, specifically for the detection of glycosidase activities involved in the breakdown of sugars. This compound is vital in studying various diseases such as genetic disorders and lysosomal storage diseases where abnormal glycosidase activity is observed. Synonyms: 4-Methylumbelliferyl lewis X trisaccharide nonaacetate glycoside. Molecular formula: C46H57NO25. Mole weight: 1023.94. | |
| 4-Nitrophenyl 2,4,6-tri-O-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)-b-D-glucopyranoside | 4-Nitrophenyl 2,4,6-tri-O-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)-b-D-glucopyranoside, a multifaceted compound, finds significant utility in the realm of biomedicine for diverse purposes. Its fundamental involvement in the intricate exploration and advancement of medicines intended to combat ailments, including cancer and inflammation, is undeniable. This indispensable product assumes a pivotal role as an invaluable instrument in the synthesis of pharmaceutical compounds, thereby garnering extensive scientific scrutiny directed towards its potential therapeutic efficacies. Synonyms: [(2R,3R,4S,5R,6S)-3,4,5-Triacetyloxy-6-[(2R,3R,4S,5R,6S)-3,5-diacetyloxy-2-(acetyloxymethyl)-6-(4-nitrophenoxy)oxan-4-yl]oxyoxan-2-yl]methyl acetate; (2R,3R,4S,5R,6S)-2-(Acetoxymethyl)-6-(((2R,3R,4S,5R,6S)-3,5-diacetoxy-2-(acetoxymethyl)-6-(4-nitrophenoxy)tetrahydro-2H-pyran-4-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate; DTXSID60440943; 4-Nitrophenyl 2,4,6-tri-O-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)-b-D-glucopyranoside; 4-Nitrophenyl 3-O-(2,3,4,6-Tetra-O-acetyl-|A-D-glucopyranosyl)-|A-D-glucopyranoside 2,4,6-Triacetate; [(2R,3R,4S,5R,6S)-3,5-BIS(ACETYLOXY)-6-(4-NITROPHENOXY)-4-{[(2S,3R,4S,5R,6R)-3,4,5-TRIS(ACETYLOXY)-6-[(ACETYLOXY)METHYL]OXAN-2-YL]OXY}OXAN-2-YL]METHYL ACETATE; 4-NITROPHENYL 2,4,6-TRI-O-ACETYL-3-O-(2,3,4,6-TETRA-O-ACETYL -BETA-D-GLUCOPYRANOSYL)-B-D-GLUCOPYRANOSIDE. CAS No. 195715-98-1. Molecular formula: C32H39NO20. Mole weight: 757.65. | |
| Acarbose tridecaacetate | Acarbose tridecaacetate - an alpha-glucosidase inhibitor utilized in managing type 2 diabetes mellitus, enables the delay in carbohydrate digestion and absorption, thus regulating postprandial glucose levels. Synonyms: O-2,3-Di-O-acetyl-4,6-dideoxy-4-[[4,5,6-tris(acetyloxy)-3-[(acetyloxy)methyl]-2-cyclohexen-1-yl]amino]-a-D-glucopyranosyl-(1-4)-O-2,3,6-tri-O-acetyl-a-D-glucopyranosyl-(1-4)-a-D-glucopyranose 1,2,3,6-tetraacetate. CAS No. 117065-98-2. Molecular formula: C51H69NO31. Mole weight: 1192.08. | |
| Aloin Peracetate | Aloin Peracetate. Group: Biochemicals. Alternative Names: (S)-1,5-Anhydro-1-C-[4,5,10-tris(acetyloxy)-2-[(acetyloxy)methyl]-9-anthracenyl]-D-glucitol Tetracetate. Grades: Highly Purified. CAS No. 64951-96-8. Pack Sizes: 50mg. Molecular Formula: C37H38O17, Molecular Weight: 754.69. US Biological Life Sciences. | Worldwide |
| Aminobutyl-DOTA-tris(t-butyl ester) | Aminobutyl-DOTA-tris(t-butyl ester) is a bifunctional chelating agent. Synonyms: Tri-tert-butyl 2,2',2''-(10-(2-((4-aminobutyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate; 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(t-butyl acetate)-10-(4-aminobutyl)acetamide. CAS No. 1402393-59-2. Molecular formula: C32H62N6O7. Mole weight: 642.87. | |
| Amylostatin XG Octaacetate | Amylostatin XG Octaacetate is a protected intermediate of Amylostatin XG, an analogue of an α-glucosidase inhibitor, Acarbose. Synonyms: [1S-(1α, 4α, 5β, 6α)]-4-O-[2, 3-Di-O-acetyl-4, 6-dideoxy-4-[[4, 5, 6-tris(acetyloxy)-3-[(acetyloxy)methyl]-2-cyclohexen-1-yl]amino]-α-D-glucopyranosyl]-D-glucopyranose. CAS No. 85747-82-6. Molecular formula: C39H53NO23. Mole weight: 903.83. | |
| ATP Citrate Lyase Active from Human, Recombinant | ATP Citrate lyase is an enzyme involved in fatty acid synthesis that generates cytosolic acetyl-CoA and oxaloacetate from Citrate and CoA. ATP Citrate lyase is often upregulated in cancer. Applications: Active human atp citrate lyase is useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. active human atp citrate lyase has been used in a study to ascertain the nature of the catalytic phosphorylation that initiates the acl reaction, and to identity the active site residues involved. active human atp citrate lyase has also been used in a study to analyze tumor metabolism to reveal mitochondrial glucose oxidation in genetically diverse human glioblastomas. Group: Enzymes. S. Purity: > 90% (SDS-PAGE). ACLY. Mole weight: 147 kDa. Storage: Store at -70°C. Avoid multiple freeze-thaw cycles. Form: Aqueous solution, Formulated in 25 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.05% Tween-20 and 10% glycerol. Source: Baculovirus. Species: Human. ACLY; ATP-Citrate synthase; ATPCL; CLATP; ATP-citric lyase; ATP:Citrate oxaloacetate-lyase [(pro-S)-CH2COO-->acetyl-CoA] (ATP-dephosphorylating); acetyl-CoA:oxaloacetate acetyltransferase (isomerizing; ADP-phosphorylating); adenosine triphosphate Citrate lyase; Citrate cleavage enzyme; Citrate-ATP lyase; citric cleavage enzyme; ATP Citrate (pro-S)-lyase. Cat No: NATE-0944. |  |
| Benzyl 2,3,4-Tri-O-benzyl-D-glucuronate Acetate | Benzyl 2,3,4-Tri-O-benzyl-D-glucuronate Acetate is an extensively employed chemical compound within the biomedical realm, holding great significance for the research and development of disease-specific drugs. Synonyms: 2,3,4-Tris-O-(phenylmethyl)-D-glucopyranuronic Acid Phenylmethyl Ester Acetate; 2,3,4-Tris-O-(phenylmethyl)-D-glucopyranuronic Acid Benzyl Ester Acetate. CAS No. 4550-93-0. Molecular formula: C36H36O8. Mole weight: 596.67. | |
| Benzyl 2-Acetamido-3,4-di-O-acetyl-2-deoxy-6-O-(tri-O-benzyl-L-fucopyranosyl)-α-D-glucopyranoside (4:1 α/β mixture) | Benzyl 2-Acetamido-3,4-di-O-acetyl-2-deoxy-6-O-(tri-O-benzyl-L-fucopyranosyl)-α-D-glucopyranoside (4:1 α/β mixture) is an intricate molecule, finding applications in studying numerous ailments, encompassing malignancies and infectious disorders. Synonyms: [(2R,3S,4R,5R,6S)-5-acetamido-4-acetyloxy-2-[[(2R,3S,4R,5R,6S)-6-methyl-3,4,5-tris(phenylmethoxy)oxan-2-yl]oxymethyl]-6-phenylmethoxyoxan-3-yl] acetate; Benzyl 2-Acetamido-3,4-di-O-acetyl-2-deoxy-6-O-(tri-O-benzyl-L-fucopyranosyl)-alpha-D-glucopyranoside (; DTXSID90747098; Benzyl 2-acetamido-3,4-di-O-acetyl-2-deoxy-6-O-(2,3,4-tri-O-benzyl-6-deoxy-alpha-L-galactopyranosyl)-alpha-D-glucopyranoside; Benzyl 2-Acetamido-3,4-di-O-acetyl-2-deoxy-6-O-(tri-O-benzyl-L-fucopyranosyl)-a-D-glucopyranoside (4:1 a/b mixture). CAS No. 33639-78-0. Molecular formula: C46H53NO12. Mole weight: 811.91. | |
| Bismuth(III) acetate | Bismuth(III) acetate. Group: Solution deposition precursors. Alternative Names: HSDB 2186; CTK4E9160; bismuth(3+) ion tris(acetate ion); 8AJA86Y692; AKOS015915836; NSC 370498; Bismuth(III) acetate; EINECS 249-426-0; KS-000018GP; Acetic acid, bismuth(3+) salt. CAS No. 22306-37-2. Product ID: bismuth; triacetate. Molecular formula: 386.112g/mol. Mole weight: Bi(C2H3O2)3;C6H9BiO6. CC(=O)[O-]. CC(=O)[O-]. CC(=O)[O-]. [Bi+3]. InChI=1S/3C2H4O2.Bi/c3*1-2(3)4; /h3*1H3, (H, 3, 4); /q; ; ; +3/p-3. WKLWZEWIYUTZNJ-UHFFFAOYSA-K. |  |
| Bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | Bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine (CAS# 90852-19-0 ) is a useful research chemical. Synonyms: [(1S,3R,4S,6R)-2,3-diacetyloxy-4,6-diazidocyclohexyl] acetate. CAS No. 90852-19-0. Molecular formula: C12H16N6O6. Mole weight: 340.29. | |
| Bis(tri-o-tolylphosphine)palladium(II) Dichloride | Coupling reaction of aryl bromides with vinylic acetates. Group: Palladium series catalysts. Alternative Names: 5531AB; SC10409; MFCD00274659 (98%); dichlorobis(tri-o-tolyl-phosphine)palladium(II); dichlorobis(tri-O-tolylphosphine)-palladium (II); DICHLOROBIS(TRI-ORTHO-TOLYLPHOSPHINE)PALLADIUM(II); FT-0696077; bis[tri(ortho-tolyl)phosphine] palladium chloride; Dichlorobis(tri-o-tolylphosphine)palladium; AK-76768. CAS No. 40691-33-6. Molecular formula: C42H42Cl2P2Pd. Mole weight: 786.066g/mol. IUPACName: dichloropalladium;tris(2-methylphenyl)phosphane. Canonical SMILES: CC1=CC=CC=C1P (C2=CC=CC=C2C)C3=CC=CC=C3C. CC1=CC=CC=C1P (C2=CC=CC=C2C)C3=CC=CC=C3C. Cl[Pd]Cl. Catalog: ACM40691336. | |
| CALX8 | Anionic Detergents. Alternative Names: 26, 27, 28-Trihydroxy-25-(octyloxy)-pentacyclo[19.3.1.13, 7.19, 13.115, 19]octacosa-1(25), 3, 5, 7(28), 9, 11, 13(27), 15, 17, 19(26), 21, 23-dodecaene-5, 11, 17-triacetic acid, trisodium salt. CAS No. 1872296-37-1. Molecular formula: C42H43O103Na. Mole weight: 776.8. Appearance: Beige powder. IUPACName: trisodium;2-[11, 17-bis(carboxylatomethyl)-26, 27, 28-trihydroxy-25-octoxy-5-pentacyclo[19.3.1.13, 7.19, 13.115, 19]octacosa-1(24), 3(28), 4, 6, 9, 11, 13(27), 15, 17, 19(26), 21(25), 22-dodecaenyl]acetate. | |
| CALXCHOL | Non-ionic Detergents. Alternative Names: 25-[[1-(3α)-Cholest-5-en-3-yl-1H-1, 2, 3-triazol-4-yl]methoxy]-26, 27, 28-trihydroxy-pentacyclo[19.3.1.13, 7.19, 13.115, 19]octacosa-1(25), 3, 5, 7(28), 9, 11, 13(27), 15, 17, 19(26), 21, 23-dodecaene-5, 11, 17-triacetic acid, trisodium salt. CAS No. 2121543-66-4. Molecular formula: C64H74N3O10Na3. Mole weight: 1114.3. Appearance: Beige powder. Purity: ≥85%. IUPACName: trisodium;2-[11, 17-bis(carboxylatomethyl)-25-[[1-[(3R, 8S, 9S, 10R, 13R, 14S, 17R)-10, 13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2, 3, 4, 7, 8, 9, 11, 12, 14, 15, 16, 17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]triazol-4-yl]methoxy]-26, 27, 28-trihydroxy-5-pentacyclo[19.3.1.13, 7.19, 13.115, 19]octacosa-1(24), 3(28), 4, 6, 9, 11, 13(27), 15, 17, 19(26), 21(25), 22-dodecaenyl]acetate. | |
| Cyanomethyl 2,3,4,6-tetra-O-acetyl-b-D-thiogalactopyranoside | Cyanomethyl 2,3,4,6-tetra-O-acetyl-b-D-thiogalactopyranoside is a versatile compound used in biomedicine. It acts as a substrate analog for β-galactosidase enzyme assays, aiding in the detection and quantification of this enzyme. Additionally, it can be employed for the synthesis of various drugs targeting diseases related to galactosyltransferase enzymes. This compound's unique structure and reactivity make it an essential tool in biomedical research and drug development. Synonyms: Cyanomethyl 2,3,4,6-tetra-O-acetyl-1-thio-beta-D-galactopyranoside; MFCD00057536; (2R,3S,4S,5R,6S)-2-(Acetoxymethyl)-6-((cyanomethyl)thio)tetrahydro-2H-pyran-3,4,5-triyl triacetate; [(2R,3S,4S,5R,6S)-3,4,5-TRIS(ACETYLOXY)-6-[(CYANOMETHYL)SULFANYL]OXAN-2-YL]METHYL ACETATE; ZNQCXCWNORCJGV-CWVYHPPDSA-N; SCHEMBL1140693; Cyanomethyl 2,3,4,6-tetra-O-acetyl-b-D-thiogalactopyranoside; AKOS022179223; AS-72153; CS-0205233; E86931; W-203283; Cyanomethyl2,3,4,6-tetra-O-acetyl-|A-D-thiogalactopyranoside; Cyanomethyl 2,3,4,6-Tetra-O-acetyl-1-thio-ss-D-galactopyranoside; (2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(cyanomethylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate. CAS No. 61145-33-3. Molecular formula: C16H21NO9S. Mole weight: 403.41. | |
| Diethylenetriamine-pentaacetic acid copper(II)trisodium salt hemihydrate | Heterocyclic Organic Compound. Alternative Names: Diethylenetriamine-pentaacetic acid copper(II) trisodium salt hemihydrate. CAS No. 12189-76-3. Molecular formula: C14H18CuN3Na3O10·0.5H2O. Mole weight: 529.83. Purity: 0.96. IUPACName: copper trisodium 2-[bis[2-[bis(2-oxido-2-oxoethyl)amino]ethyl]amino]acetate. Canonical SMILES: C (CN (CC (=O)[O-])CC (=O)[O-])N (CCN (CC (=O)[O-])CC (=O)[O-])CC (=O)[O-]. [Na+]. [Na+]. [Na+]. [Cu+2]. ECNumber: 235-361-5. Catalog: ACM12189763. | |
| DOTA-tris(tert-butyl ester) | Synonyms: Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate; 2-(4,7,10-Tris(2-(tert-butoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetic acid; DOTA(OtBu) hydrobromide salt. Grades: 95%. CAS No. 137076-54-1. Molecular formula: C28H52N4O8. Mole weight: 572.7. | |
| Endoglycosidase F3 from Elizabethkingia miricola, Recombinant | An Endoglycosidase is an enzyme that releases oligosaccharides from glycoproteins or glycolipids. It may also cleave polysaccharide chains between residues that are not the terminal residue, although releasing oligosaccharides from conjugated protein and lipid molecules is more common. It breaks the glycosidic bonds between two sugar monomer in the polymer. It is different from exoglycosidase that it does not do so at the terminal residue. Hence, it is used to release long carbohydrates from conjugated molecules. If an exoglycosidase were used, every monomer in the polymer would have to be removed, one by one from the chain, taking a long time. An endoglycosidase cleaves, giving a polymeric product. Group: Enzymes. Synonyms: Endoglycosidase F3; Elizabethkingia miricola; Endo-β-N-. Enzyme Commission Number: EC 3.2.1.96. CAS No. 231-791-2. Endo-β-N-acetylglucosaminidase. Activity: 30 U/mg. Storage: 2-8°C. Form: Aseptically filled solution in 20 mM Tris-HCl, pH 7.5. Source: E. coli. Species: Elizabethkingia miricola. Endoglycosidase F3; Elizabethkingia miricola; Endo-β-N-acetylglucosaminidase F3; Endoglycosidase F3 from Elizabethkingia (Chryseobacterium/Flavobacterium) meningosepticum; EC 3.2.1.96; 231-791-2; Endo F3. Pack: Supplied with 5× Reaction Buffer, 250 mM sodium acetate, pH 4.5. Cat No: NATE-0216. | |
| Ethyl 2,3,4,6-tetra-O-acetyl-a-D-thiogalactopyranoside | Ethyl 2,3,4,6-tetra-O-acetyl-α-D-thiogalactopyranoside is a substrate analog for beta-D-galactosidase, enabling the detection and study of enzyme kinetics. This versatile product is widely employed in the development and validation of novel drugs targeting lysosomal storage diseases, such as Gaucher's disease. Synonyms: Ethyl 2,3,4,6-Tetra-O-acetyl-alpha-D-thiogalactopyranoside; [(2R,3S,4S,5R,6R)-3,4,5-triacetyloxy-6-ethylsulfanyloxan-2-yl]methyl acetate; alpha-D-Galactopyranoside, ethyl 1-thio-, 2,3,4,6-tetraacetate; (2R,3S,4S,5R,6R)-2-(acetoxymethyl)-6-(ethylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate; [(2R,3S,4S,5R,6R)-3,4,5-TRIS(ACETYLOXY)-6-(ETHYLSULFANYL)OXAN-2-YL]METHYL ACETATE. CAS No. 126187-25-5. Molecular formula: C16H24O9S. Mole weight: 392.42. | |
| Glycine, N, N-1, 2-ethanediylbis(N-(carboxymethyl)-, trisodium salt,hydrate | Glycine, N, N-1, 2-ethanediylbis(N-(carboxymethyl)-, trisodium salt,hydrate. Group: Salt. CAS No. 85715-60-2. Product ID: trisodium; 2-[2-[bis (carboxylatomethyl)amino]ethyl- (carboxymethyl)amino]acetate; hydrate. Molecular formula: 376.2g/mol. Mole weight: C10H15N2Na3O9. C (CN (CC (=O)[O-])CC (=O)[O-])N (CC (=O)O)CC (=O)[O-]. O. [Na+]. [Na+]. [Na+]. InChI=1S/C10H16N2O8. 3Na. H2O/c13-7 (14)3-11 (4-8 (15)16)1-2-12 (5-9 (17)18)6-10 (19)20; ; ; ; /h1-6H2, (H, 13, 14) (H, 15, 16) (H, 17, 18) (H, 19, 20); ; ; ; 1H2/q; 3*+1; /p-3. KKTNQJMZBPLVKM-UHFFFAOYSA-K. >98.0%(T). | |
| Heptatrimethylsilyl D-Lactose Acetate | Heptatrimethylsilyl D-Lactose Acetate is an intermediate in synthesizing Cetirizine 6,6'-O-Lactose Ester Dihydrochloride(6,6'-Mixture), a lactose adduct of Cetirizine. Synonyms: (3R, 4S, 5R, 6R) -3, 4-Bis ( (trimethylsilyl) oxy) -6- ( ( (trimethylsilyl) oxy) methyl) -5- ( ( (2S, 3R, 4S, 5S, 6R) -3, 4, 5-tris ( (trimethylsilyl) oxy) -6- ( ( (trimethylsilyl) oxy) methyl) tetrahydro-2H-pyran-2-yl) oxy) tetrahydro-2H-pyran-2-yl Acetate. Molecular formula: C35H80O12Si7. Mole weight: 889.6. | |
| Hexatrimethylsilyl D-Lactose-6-[1-((4-chlorophenyl)(phenyl)methyl)-4-(2-methoxyethyl)piperazine] Ester | Hexatrimethylsilyl D-Lactose-6-[1-((4-chlorophenyl)(phenyl)methyl)-4-(2-methoxyethyl)piperazine] Ester is an intermediate in synthesizing Cetirizine 6,6'-O-Lactose Ester Dihydrochloride(6,6'-Mixture), a lactose adduct of Cetirizine. Synonyms: ( (2R, 3R, 4S, 5R, 6S) -4, 5, 6-Tris ( (trimethylsilyl) oxy) -3- ( ( (2S, 3R, 4S, 5S, 6R) -3, 4, 5-tris ( (trimethylsilyl) oxy) -6- ( ( (trimethylsilyl) oxy) methyl) tetrahydro-2H-pyran-2-yl) oxy) tetrahydro-2H-pyran-2-yl) methyl 2- (2- (4- ( (4-Chlorophenyl) (phenyl)methyl)piperazin-1-yl)ethoxy)acetate. Molecular formula: C54H101ClN2O13Si7. Mole weight: 1218.44. | |
| Hexatrimethylsilyl D-Lactose-6'-[1-((4-chlorophenyl)(phenyl)methyl)-4-(2-methoxyethyl)piperazine] Ester | Hexatrimethylsilyl D-Lactose-6'-[1-((4-chlorophenyl)(phenyl)methyl)-4-(2-methoxyethyl)piperazine] Ester is an intermediate in synthesizing Cetirizine 6,6'-O-Lactose Ester Dihydrochloride (6,6'-Mixture), a lactose adduct of Cetirizine. Synonyms: ( (2R, 3S, 4S, 5R, 6S) -3, 4, 5-Tris ( (trimethylsilyl) oxy) -6- ( ( (2R, 3R, 4S, 5R, 6S) -4, 5, 6-tris ( (trimethylsilyl) oxy) -2- ( ( (trimethylsilyl) oxy) methyl) tetrahydro-2H-pyran-3-yl) oxy) tetrahydro-2H-pyran-2-yl) methyl 2- (2- (4- ( (4-Chlorophenyl) (phenyl)methyl)piperazin-1-yl)ethoxy)acetate. Molecular formula: C54H101ClN2O13Si7. Mole weight: 1218.44. | |
| HIV Protease Mutant, Recombinant | HIV-1 protease is a retroviral aspartyl protease (retropepsin) that is essential for the life-cycle of HIV, the retrovirus that causes AIDS. HIV protease cleaves newly synthesized polyproteins at the appropriate places to create the mature protein components of an infectious HIV virion. Without effective HIV protease, HIV virions remain uninfectious. Thus, mutation of HIV protease's active site or inhibition of its activity disrupts HIVs ability to replicate and infect additional cells, making HIV protease inhibition the subject of considerable pharmaceutical research. Group: Enzymes. Synonyms: human immunodeficiency virus type 1 protease; gag protease; HIV aspartyl protease; HIV proteinase; retroproteinase; HIV-1 protease; HIV-2 protease; HIV-1 retropepsin; HIV Protease Mutant; EC 3.4.23.16. Enzyme Commission Number: EC 3.4.23.16. CAS No. 144114-21-6. HIV Protease. Mole weight: mol wt ~10.8 kDa. Storage: -70°C. Form: Supplied as a solution in 0.5M Sodium Acetate, pH 4.7with 50mM Tris-HCL, 1M NaCL, 1mM EDTA, 5mM DTT and 15% glycerol. Source: E. coli. human immunodeficiency virus type 1 protease; gag protease; HIV aspartyl protease; HIV proteinase; retroproteinase; HIV-1 protease; HIV-2 protease; HIV-1 retropepsin; HIV Protease Mutant; EC 3.4.23.16. Pack: 100 unit vial containing > 100ug protein. Cat No: NATE-0344. | |
| Holmium(III) sulfate | Erbium (III) Acetate Hydrate is an important colourant in glasses and porcelain enamel glazes. High purity Erbium (III) Acetate Hydrate is widely applied as dopant in making optical fibre and amplifier. It is particularly useful as an amplifier for fiber optic data transfer. Group: Metal & ceramic materials. Alternative Names: sulfuricacid, holmium(3++)salt(3:2);HOLMIUM(III) SULFATE99.99+%;Holmium (III) sulfate hydrate (99.9%-Ho) (REO);diholmium(3+) trisulphate;Holmium(?) sulfate;Holmium sulfate hydrate, 99.99%;HOLMIUM SULFATE, 99.9%;HOLMIUM(III) SULFATE HYDRATE: 99.99%. CAS No. 15622-40-9. Molecular formula: Ho2(SO4)3. Mole weight: 618.05. Appearance: Light orange crystal, no odor. Purity: 0.96. IUPACName: holmium(3+) trisulfate. Canonical SMILES: [O-]S(=O)(=O)[O-]. [O-]S(=O)(=O)[O-]. [O-]S(=O)(=O)[O-]. [Ho+3]. [Ho+3]. ECNumber: 239-697-3. Catalog: ACM15622409. | |
| Immobilized Endoproteinase Glu-C on F7m | Endoproteinase Glu-C hydrolyzes peptide and ester linkages specifically at the carboxyl end of glutamic acid (-Glu/-X; in ammonium carbonate pH 7. 8, or ammonium acetate pH 4. 0, buffer A) or of glutamic and aspartic acid (-Glu/-X and -Asp/-X; in phosphate buffer pH 7. 8, buffer B). F7m: 1. 0 mg endoproteinase Glu-C immobilized on matrix F7m per CR-column. 900 units immobilized per CR-column. Nr. 7 Storage buffer: 50 mM Tris/HCl at pH 7. 5, 5 mM EDTA. Nr. 31 Reaction buffer A: 25 mM ammonium acetate, pH 4. 0 (see above)Nr. 32 Washing buffer A: 25 mM ammonium acetate, pH 4. 0, 1 M NaClNr. 62 Reaction buffer B: 50 mM phosphate buffer, pH 7. 8 (see above)Nr. 63 Washing buffer B: 50 mM phosphate buffer, pH 7. 8, 1 M NaCl. Group: Enzymes. Synonyms: EC 3. 4. 21. 19; Staph aureus V8 Protease; Protease, Staph aureus (Endoproteinase Glu-C); Glutamyl endopeptidase; V8 proteinase, endoproteinase Glu-C; staphylococcal serine proteinase. Enzyme Commission Number: EC 3. 4. 21. 19. Storage: 4 °C. Source: Staphylococcus aureus. EC 3. 4. 21. 19; Staph aureus V8 Protease; Protease, Staph aureus (Endoproteinase Glu-C); Glutamyl endopeptidase; V8 proteinase, endoproteinase Glu-C; staphylococcal serine proteinase; Immobilized Endoproteinase Glu-C. Cat No: NATE-1763. | |
| Immobilized Endoproteinase Glu-C on G3m | Endoproteinase Glu-C hydrolyzes peptide and ester linkages specifically at the carboxyl end of glutamic acid (-Glu/-X; in ammonium carbonate pH 7. 8, or ammonium acetate pH 4. 0, buffer A) or of glutamic and aspartic acid (-Glu/-X and -Asp/-X; in phosphate buffer pH 7. 8, buffer B). G3m: 25 ug (22 units) endoproteinase Glu-C per CR-column immobilized on dextran. This CR-column cuts at least 12 ug tubulin or 5 ug BSA per application in phosphate buffer. Nr. 7 Storage buffer: 50 mM Tris/HCl at pH 7. 5, 5 mM EDTA. Nr. 31 Reaction buffer: 25 mM NH4-acetate, pH 4. 0 (see above)Nr. 32 Washing buffer: 25 mM NH4-acetate, pH 4. 0, 1 M NaClNr. 62 Reaction buffer: 50 mM phosphate buffer, pH 7. 8 (see above)Nr. 63 Washing buffer: 50 mM phosphate buffer, pH 7. 8, 1 M NaCl. Group: Enzymes. Synonyms: EC 3. 4. 21. 19; Staph aureus V8 Protease; Protease, Staph aureus (Endoproteinase Glu-C); Glutamyl endopeptidase; V8 proteinase, endoproteinase Glu-C; staphylococcal serine proteinase. Enzyme Commission Number: EC 3. 4. 21. 19. Storage: 4 °C. Source: Staphylococcus aureus. EC 3. 4. 21. 19; Staph aureus V8 Protease; Protease, Staph aureus (Endoproteinase Glu-C); Glutamyl endopeptidase; V8 proteinase, endoproteinase Glu-C; staphylococcal serine proteinase; Immobilized Endoproteinase Glu-C. Cat No: NATE-1764. | |
| Linaclotide acetate | Linaclotide is an oligo-peptide agonist of guanylate cyclase 2C. It can be used for the treatment in adults of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation. Uses: Constipation; irritable bowel syndrome. Synonyms: L-Tyrosine, L-cysteinyl-L-cysteinyl-L-α-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (1?6),(2?10),(5?13)-tris(disulfide), acetate (1:1); L-Tyrosine, L-cysteinyl-L-cysteinyl-L-α-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (1?6),(2?10),(5?13)-tris(disulfide), monoacetate (salt); Linaclotide monoacetate; MM 416775; H-Cys-Cys-Glu-Tyr-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr-OH.CH3CO2H (Disulfide bridge: Cys1-Cys6, Cys2-Cys10, Cys5-Cys13). Grades: 95%. CAS No. 851199-60-5. Molecular formula: C61H83N15O23S6. Mole weight: 1586.80. | |
| Mangafodipir trisodium | Mangafodipir trisodium (MnDPDP), hepatocellular-specific contrast agent, is an efficacious inhibitor of CIPN (chemotherapy-induced peripheral neuropath) and other conditions caused by cellular oxidative stress. Mangafodipir trisodium shows no negative interference with the tumoricidal activity of chemotherapy. Group: Inhibitors. Alternative Names: Trisodium; 2-[2-[carboxylatomethyl-[[2-methyl-3-oxido-5-(phosphonatooxymethyl)pyridin-4-yl]methyl]amino]ethyl-[[2-methyl-3-oxido-5-(phosphonatooxymethyl)pyridin-4-yl]methyl]amino]acetate; hydron; manganese(2+). CAS No. 140678-14-4. Molecular formula: C22H27MnN4Na3O14P2. Mole weight: 757.32. Appearance: Solid. Purity: 0.98. Canonical SMILES: [H+]. [H+]. [H+]. CC1=NC=C (C (=C1[O-])CN (CCN (CC2=C (C (=NC=C2COP (=O) ([O-])[O-])C)[O-])CC (=O)[O-])CC (=O)[O-])COP (=O) ([O-])[O-]. [Na+]. [Na+]. [Na+]. [Mn+2]. Catalog: ACM140678144. | |
| Native Bovine Pyruvate Carboxylase | Pyruvate carboxylase catalyzes the carboxylation of pyruvate to oxaloacetate. Pyruvate carboxylase is a mitochondrial protein that has a biotin prosthetic group that requiries magnesium or manganese and acetyl CoA. Applications: Pyruvate is critical for gluconeogenesis, lipogenesis, glyceroneogenesis, neurotransmitter biosynthesis and glucose-induced insulin, and is used to study these pr ocesses. the enzyme from creative enzymes has been used as a positive control during the assay of pyruvate carboxylase activity in cell-free extracts of corynebacterium glutamicum. Group: Enzymes. Synonyms: Pyruvate carboxylase; PC; EC 6.4.1.1; 9014-19-1; pyruvic carboxylase. Enzyme Commission Number: EC 6.4.1.1. CAS No. 9014-19-1. PC. Activity: 5-25 units/mg protein (BCA). Storage: -20°C. Form: buffered aqueous glycerol solution; Solution in 50% glycerol containing 0.05 M Tris-HCl, pH 7.4, 2 mM magnesium acetate and 1 mM EDTA. Source: Bovine liver. Species: Bovine. Pyruvate carboxylase; PC; EC 6.4.1.1; 9014-19-1; pyruvic carboxylase. Cat No: NATE-0508. | |
| Native Escherichia coli β-Galactosidase-biotin labeled | β-galactosidase is a hydrolase enzyme that catalyzes the hydrolysis of β-galactosides into monosaccharides. Substrates of different β-galactosidases include ganglioside GM1, lactosylceramides, lactose, and various glycoproteins. Applications: Β-galactosidase was used as a control antigen in the selection of human antibody fragments by phage display. Group: Enzymes. Synonyms: β-galactosidase; beta-gal; β-gal; EC 3.2.1.23; lactase; β-lactosidase; maxilact; hydrolact; β-D-lactosidase; S 2107; lactozym; trilactase; β-D-galactanase; oryzatym; sumiklat; β-D-galactoside galactohydrolase. β-gal. Activity: 350-1200 units/mg protein. Form: Lyophilized powder containing Tris-acetate, DTT, MgCl2, and isopropyl β-D-thiogalactopyranoside. Source: E. coli. β-galactosidase; beta-gal; β-gal; EC 3.2.1.23; lactase; β-lactosidase; maxilact; hydrolact; β-D-lactosidase; S 2107; lactozym; trilactase; β-D-galactanase; oryzatym; sumiklat; β-D-galactoside galactohydrolase; β-Galactosidase-biotin labeled; biotin β-gal. Cat No: NATE-1585. | |
| Native Flavobacterium heparinum 2-O-Sulfatase | Hydrolyses the terminal 2-O-sulphate on the unsaturated di-and oligo-saccharides produced by the action of lyases on sulphated glycosaminoglycans. Hydrolyses the terminal 2-o-sulphate on the unsaturated di-and oligo-saccharides produced by the action of lyases on sulphated glycosaminoglycans. Applications: 2-o-sulfatase from flavobacterium heparinum has been used in a study to determine that oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. 2-o-sulfatase from flavobacterium heparinum has also been used in a study to determine the structure of oligosaccharides prepared from acharan sulfate. Group: Enzymes. Synonyms: 2-O-Sulfatase. 2-O-Sulfatase. Activity: 10-40 (units/ml). Storage: -20°C. Form: Solution contains 10 mM tris-acetate, pH 7.3, 80 mM NaCl, 10 mM potassium phosphate, 0.2% BSA. Source: Flavobacterium heparinum. 2-O-Sulfatase. Cat No: NATE-0002. | |
| Native Porcine Creatine Kinase | Creatine Kinase is an enzyme present in muscle, brain, and other tissues of vertebrates that catalyzes the reversible conversion of ADP and phosphocreatine into ATP and creatine. Elevated levels of creatine phosphokinase indicates possible Brain injury or stroke, convulsions, delirium tremens, Dermatomyositis or polymyositis, electric shock, Heart attack, Inflammation of the heart muscle (myocarditis), Lung tissue death (pulmonary infarction), Muscular dystrophies and Myopathy. Group: Enzymes. Synonyms: EC 2.7.3.2; ATP:creatine phosphotransferase; CK; CPK; creatine phosphokinase; creatine phosphotransferase; phosphocreatine kinase; adenosine triphosphate-creatine transphosphorylase; 9001-15-4. Enzyme Commission Number: EC 2.7.3.2. CAS No. 9001-15-4. Activity: > 300 U/mg. Appearance: Reddish to pink lyophilized powder. Storage: Store at -20° C. Form: Lyophilized from tris acetate, DTT and EDTA, pH: 7.0. Source: Porcine Heart. Species: Porcine. EC 2.7.3.2; ATP:creatine phosphotransferase; CK; CPK; creatine phosphokinase; creatine phosphotransferase; phosphocreatine kinase; adenosine triphosphate-creatine transphosphorylase; 9001-15-4. Cat No: NATE-1884. | |
| Native Pseudomonas lemoignei β-Hydroxybutyrate Dehydrogenase | In mammalian systems, β-hydroxybutyrate dehydrogenase is localized on the inner mitochondrial membrane and requires phosphatidyl choline for activity. In contrast, the enzyme from Pseudomonas is a soluble cytosolic enzyme that does not require a phospholipid allosteric activator. The enzyme is required for the utilization of ketone bodies as a source of metabolic energy. It catalyzes the oxidation of 3-hydroxybutyrate to acetoacetate, the first step in the conversion of ketone bodies to citric acid, which is then further metabolized via the tricarboxylic acid cycle (Krebs cycle). Applications: Suitable for the determination of acetoacetate and d (-)-3-hy...1.1.30; 9028-38-0. Enzyme Commission Number: EC 1.1.1.30. CAS No. 9028-38-0. 3-HBDH. Activity: > 200 units/mg protein. Storage: -20°C. Form: Lyophilized powder containing sucrose, β-NAD and Tris buffer salts. Source: Pseudomonas lemoignei. 3-hydroxybutyrate dehydrogenase; 3-HBDH; NAD-β-hydroxybutyRate dehydrogenase; hydroxybutyRate oxidoreductase; β-hydroxybutyRate dehydrogenase; D-β-hydroxybutyRate dehydrogenase; D-3-hydroxybutyRate dehydrogenase; D-(-)-3-hydroxybutyRate dehydrogenase; β-hydroxybutyric acid dehydrogenase; 3-D-hydroxybutyRate dehydrogenase; β-hydroxybutyric dehydrogenase; EC 1.1.1.30; 9028-38-0. Cat No: NATE-0003. | |
| Native Rhodopseudomonas sphaeroides β-Hydroxybutyrate Dehydrogenase | In mammalian systems, β-hydroxybutyrate dehydrogenase is localized on the inner mitochondrial membrane and requires phosphatidyl choline for activity. In contrast, the enzyme from Pseudomonas is a soluble cytosolic enzyme that does not require a phospholipid allosteric activator. The enzyme is required for the utilization of ketone bodies as a source of metabolic energy. It catalyzes the oxidation of 3-hydroxybutyrate to acetoacetate, the first step in the conversion of ketone bodies to citric acid, which is then further metabolized via the tricarboxylic acid cycle (Krebs cycle). Applications: Suitable for the determination of acetoacetate and d (-)-3...nase; EC 1.1.1.30; 9028-38-0. Enzyme Commission Number: EC 1.1.1.30. CAS No. 9028-38-0. 3-HBDH. Activity: 250-750 units/mg protein. Storage: -20°C. Form: Lyophilized powder containing Tris buffer salts. Source: Rhodopseudomonas sphaeroides. 3-hydroxybutyrate dehydrogenase; 3-HBDH; NAD-β-hydroxybutyRate dehydrogenase; hydroxybutyRate oxidoreductase; β-hydroxybutyRate dehydrogenase; D-β-hydroxybutyRate dehydrogenase; D-3-hydroxybutyRate dehydrogenase; D-(-)-3-hydroxybutyRate dehydrogenase; β-hydroxybutyric acid dehydrogenase; 3-D-hydroxybutyRate dehydrogenase; β-hydroxybutyric dehydrogenase; EC 1.1.1.30; 9028-38-0. Cat No: NATE-0004. | |
| Native Tritirachium album limber Proteinase K | Proteinase K (PROK) is a serine protease with broad specificity towards aliphatic, aromatic and other hydrophobic amino acids. PROK has a molecular weight of 27,000 daltons and is Ca2+ dependent. It is not inactivated by metal ion chelating agents such as EDTA, sulfhydryl reagents, PCMB, TLCK, or TPCK. It also retains activity in 0.5% SDS. It can be inhibited by PMSF or DFP. Applications: Useful for the proteolytic inactivation of nucleases during the isolation of dna and rna. removes endotoxins that bind to cationic proteins such as lysozyme and ribonuclease a. reported useful for the isolation of hepatic, yeast, and mung bean mit ochondria determination of enzyme l o...oteinase; Tritirachium album proteinase K; endopeptidase K; 39450-01-6; protease K. Enzyme Commission Number: EC 3.4.21.64. CAS No. 39450-01-6. Purity: Purified to remove DNase and RNase. Proteinase K. Mole weight: 27 kDa. Activity: Type I, > 20 units per mg dry weight; Type II, > 400 u/ml. Storage: Powder: 2-8°C; Liquid: -20°C. Form: Type I, powder; Type II, Liquid in 20mg/ml in 10mM Tris-HCl, 1mM calcium acetate, pH 7.5 containing 50% glycerol. Source: Tritirachium album limber. Proteinase K; EC 3.4.21.64; Tritirachium alkaline proteinase; Tritirachium album serine proteinase; Tritirachium album proteinase K; endopeptidase K; 39450-01-6; protease K. Cat No: NATE-0637. | |
| (N-Succinimidyl oxycarbonyl - methyl ) tri s (2, 4, 6-tri methoxyphenyl ) phosphonium bromide | (N-Succinimidyl oxycarbonyl - methyl ) tri s (2, 4, 6-tri methoxyphenyl ) phosphonium bromide. Group: Biochemicals. Alternative Names: TMPP-ac-OSu, N-succinimidyl [tris (2, 4, 6-trimethoxyphenyl) phosphonio]acetate bromide. Grades: Highly Purified. CAS No. 226409-58-1. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C33H39BrNO13P. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
